Maxwell,
Hottod clarified a little while back that the licencing agreement with ACAD doesn't allow them to use NNZ-2591 for Retts in Nth America (and possibly ROW?). In fact doing so would be a breach of the agreement.
From my limited understanding, the approval of Tofinetide / Daybue will make the FDA path easier for NNZ-2591 pending positive trial results (of which there appears to be early indications this is even better than Trof). NEU has learnt much from Trof FDA process so I suspect we'll see quicker approval pathway.
BTW - as at 6th March there were 182k shorted Neu stocks and I'd be surprised if this didn't increased significantly over the last week. there's going to be a few shorters cancelling their chauffeured drivers and hiring electric scooters to get home (if they still own it that is).
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-4013
-
- There are more pages in this discussion • 8,151 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B |
Open | High | Low | Value | Volume |
$14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $13.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.07 | 6644 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 13.990 |
1 | 300 | 13.970 |
1 | 1432 | 13.950 |
2 | 1230 | 13.900 |
1 | 720 | 13.890 |
Price($) | Vol. | No. |
---|---|---|
14.420 | 175 | 1 |
14.500 | 2985 | 2 |
14.800 | 2850 | 2 |
14.860 | 500 | 1 |
14.960 | 445 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |